Journal Club

 

2014


Concordance between Molecular and Phenotypic Testing of Mycobacterium tuberculosis Complex Isolates for Resistance to Rifampin and Isoniazid in the United States

15.12.2014 (Daniel Goldenberger)
Yakrus MA et al.: Concordance between Molecular and Phenotypic Testing of Mycobacterium tuberculosis Complex Isolates for Resistance to Rifampin and Isoniazid in the United States J Clin Microbiol 52 1932-1937

Effects of Vaccination on Invasive Pneumococcal Disease in South Africa

08.12.2014 (Tamina Mosimann)
A.von Gottberg et al.: Effects of Vaccination on Invasive Pneumococcal Disease in South Africa NEJM 371 1980 13.11.2014

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomized, observer-masked, placebo-controlled trial

01.12.2014 (Maja Weisser)
Capeding MR: Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomized, observer-masked, placebo-controlled trial Lancet 384 1385-65 2014

Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial

24.11.2014 (Mario Kurz)
Louis Bernard: Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial The Lancet 1-8 2014

Recreational drug use, polydrug use, and sexual behaviour in HIV-diagnosed men who have sex with men in the UK:results from the cross-sectional ASTRA study

17.11.2014 (Marcel Stöckle)
Daskalopoulou M. et al.: Recreational drug use, polydrug use, and sexual behaviour in HIV-diagnosed men who have sex with men in the UK:
results from the cross-sectional ASTRA study
Lancet HIV 1 e22-e31 2014

β-Lactam Monotherapy vs β-Lactam–Macrolide Combination Treatment in Moderately Severe Community Acquired Pneumonia

10.11.2014 (Richard Kühl)
Garin N. et al.: β-Lactam Monotherapy vs β-Lactam–Macrolide Combination Treatment in Moderately Severe Community Acquired Pneumonia
JAMA Intern MedOnline: October 6, doi: 10.1001/jamainternmed.2014.4887 E1 bis E8 (online-Ausgabe)

Antibiotic treatment failure in four common infections in UK primary care 1991-2013: longitudinal analysis

27.10.2014 (Constantine Bloch-Infanger)
Craig J Currie: Antibiotic treatment failure in four common infections in UK primary care 1991-2013: longitudinal analysis BMJ 349:g5493 Keine Seitenangaben 2014

Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug users

20.10.14 (Luigia Elzi)
Barrella Harboe Z. et al.: Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug users Clin Infect Dis 59 1168-76 2014

Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis

13.10.2014 (Veronika Bättig)
Gillespie SH et al.: Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis NEJM [Epub ahead of print] 2014 Sep 7

A Systematic Review: Can One Prescribe Carbapenems to Patients With IgE-Mediated Allergy to Penicillins or Cephalosporins?

06.10.2014 (Benedikt Wiggli)
Kula B. et al.: A Systematic Review: Can One Prescribe Carbapenems to Patients With IgE-Mediated Allergy to Penicillins or Cephalosporins? CID 59(8) 1113–22 2014

Temporal Response of the Human Virome to Immunosuppression and Antiviral Therapy

29.09.2014 (Adrian Egli)
De Vlaminck I. et al.: Temporal Response of the Human Virome to Immunosuppression and Antiviral Therapy Cell 155 1178-1187 2013

Effectiveness of Clindamycin and Intravenous Immunoglobulin, and Risk of Disease in Contacts, in Invasive Group A Streptococcal Infections

15.09.14 (Florian Banderet-Uglioni)
Carapetis JR et al.: Effectiveness of Clindamycin and Intravenous Immunoglobulin, and Risk of Disease in Contacts, in Invasive Group A Streptococcal Infections CID 59 358-365 2014
http://www.ncbi.nlm.nih.gov/pubmed/25344540

Wastewater Treatment Plants Release Large Amounts of Extended-Spectrum ß-lactamse-producing Escherichia coli into the Environment

08.09.2014 (Esther Künzli)
Bréchet C et al.: Wastewater Treatment Plants Release Large Amounts of Extended-Spectrum ß-lactamse-producing Escherichia coli into the Environment CID 58 1658-1665 2014

Ritonavir-boosted darunavir combined with raltegravir or tenofovir—emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial

25.08.2014 (Jan Sidler)
Raffi F. et al.: Ritonavir-boosted darunavir combined with raltegravir or tenofovir—emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial Lancet NA (Epub ahead of print) NA (Epub ahead of print) 2014

Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial

18.08.2014 (Tamina Mosimann)
Alice C Eziefula et al.: Single dose primaquine for clearance of Plasmodium falciparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial Lancet Infect Dis 14 130-139 2014

Impact of GeneXpert MTB/RIF on Triage of Respiratory Isolation Rooms for Inpatients with Presumed TB: A Hypothetical Trial.

11.08.2014 (Michael Osthoff)
Chaisson LH: Impact of GeneXpert MTB/RIF on Triage of Respiratory Isolation Rooms for Inpatients with Presumed TB: A Hypothetical Trial. Clin Infect Dis Aug 4. pii: ciu620. [Epub ahead of print] N/a 2014

Fidaxomicin Versus Vancomycin for
Clostridium difficile Infection: Meta-analysis
of Pivotal Randomized Controlled Trials

04.08.2014 (Sarah Tschudin Sutter)
Crook D. W. et al.: Fidaxomicin Versus Vancomycin for Clostridium difficile Infection: Meta-analysis of Pivotal Randomized Controlled Trials Clin Infect Dis 55 93-103 2012

ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV

28.07.2014 (Adrian Schibli)
P. Ferenci et al.: ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV NEJM 370 (21) 1983-1992 2014

Independent contribution of bronchioalveolar lavage and serum galactomannan in the diagnosis of invasive pulmonary aspergillosis

21.07.2014 (Nina Khanna)
Fisher CE et al.: Independent contribution of bronchioalveolar lavage and serum galactomannan in the diagnosis of invasive pulmonary aspergillosis Transpl Infect Dis 16 505-510 2014

Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis

14.07.2014 (Elisabeth Wehrle)
Boulware DR et al.: Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis NEJM 370;26 2487-2498 2014
www.ncbi.nlm.nih.gov/pubmed/2522993

Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial

07.07.2014 (Manuel Battegay)
Grinsztejn B et al.: Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial Lancet Infect Dis 14 281–90 2014

Dalbavancin und Oritavancin, zwei neue Glycopeptid-Antibiotika zur Therapie von Haut und Weichteil-Infektionen

30.06.2014 (Florian Banderet-Uglioni)
1. Corey G. et al.: Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections
2. Boucher A et al.: Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection NEJM 370 1. 2180-2190 1. 2169-2176 2014

Systematic PCR Detection on Culture-negative Osteoarticular Infections

16.6.2014 (Daniel Goldenberger)
Levy PY et al.: Systematic PCR Detection on Culture-negative Osteoarticular Infections Am J Med 1143 E25-e33 2013

Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation

02.06.2014 (Mario Kurz)
Rox F. Chemaly: Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation N Engl J Med 370 1781-1789 2014

Ribavirin for Chronic Hepatitis E Virus Infection in Transplant Recipients

26.05.2014 (Bernardini Claudia)
Kamar N. et al.: Ribavirin for Chronic Hepatitis E Virus Infection in Transplant Recipients NEJM 370: 1111-20 2014

DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current β-Lactam Antibiotic Doses Sufficient for Critically Ill Patients?

19.05.2014 (Aurélien Martinez)
Roberts J. et al.: DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current β-Lactam Antibiotic Doses Sufficient for Critically Ill Patients? CID 58 (8) 1072-83 2014

Parainfluenza Virus Lower Respiratory Tract Disease After Hematopoietic Cell Transplant: Viral Detection in the Lung Predicts Outcome

05.5.2014 (Barbara Jakopp)
Sachiko et al.: Parainfluenza Virus Lower Respiratory Tract Disease After Hematopoietic Cell Transplant: Viral Detection in the Lung Predicts Outcome CID 58 Online Version; noch keine Seitenzahlen 2014

Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study

14.04.2014 (Danielle Vuichard)
Hayward AC. et al.: Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study Lancet Respir Med Published Online March 17, 2014 http://dx.doi.org/10.1016/ S2213-2600(14)70034-7 1-11 2014

Infectious Diseases Speciality Intervention Is Associated With Decreased Mortality and Lower Health Costs

07.04.2014 (Adrian Schibli)
Schmitt S. et al.: Infectious Diseases Speciality Intervention Is Associated With Decreased Mortality and Lower Health Costs CID 58 22-28 2014

Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection

24.3.2014 (Egli Adrian)
Liehl Peter et al: Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection Nature Medicine 20 47-52 2014

Impact of Rapid Organism Identification via Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Combined with Antimicrobial Stewardship Team Intervention in Adult Patients With Bacteremia and Candidemia

17.03.2014 (Michael Osthoff)
Huang AM et al.: Impact of Rapid Organism Identification via Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Combined with Antimicrobial Stewardship Team Intervention in Adult Patients With Bacteremia and Candidemia Clin Infect Dis Nov;57(9) 1237-45 2013

The cascade of HIV care in British Columbia, Canada, 1996-2011: a population-based retrospective cohort study

03.03.2014 (Veronika Bättig)
Nosyk B. et al.: The cascade of HIV care in British Columbia, Canada, 1996-2011: a population-based retrospective cohort study Lancet Infect Dis 14 40-49 2014

Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial

24.02.2014 (Esther Künzli)
Fry A. M. et al.: Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial Lancet Infect Dis 14 109-118 2014

Effect of Adequate Single-Drug vs Combination Antimicrobial Therapy on Mortality in Pseudomonas aeruginosa Bloodstream Infections: A Post Hoc Analysis of a Prospective Cohort

17.02.2014 (Aurélien Martinez)
Peña C. et al: Effect of Adequate Single-Drug vs Combination Antimicrobial Therapy on Mortality in Pseudomonas aeruginosa Bloodstream Infections: A Post Hoc Analysis of a Prospective Cohort Clin Infect Dis Jul;57(2): 208-16 2013

Predictors of virologic response in persons who start antiretroviral therapy during recent HIV infection

10.02. 2014 (Marilia Santini de Oliveira)
Karris MY et al.: Predictors of virologic response in persons who start antiretroviral therapy during recent HIV infection AIDS 3 Epub ahead of print 2014

A Trial of Mass Isoniazid Preventive Therapie for Tuberculosis Control

03.02.2014 (Florian Banderet)
Churchyard G. et al.: A Trial of Mass Isoniazid Preventive Therapie for Tuberculosis Control NEJM 370;4 301-310 2014

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection

27.01.2014 (Mario Kurz)
Mark S. Sulkowski: Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection N Engl J Med 307;3 211-221 2014

Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial

20.01.14 (Sarah Tschudin Sutter)
Derde LP et al.: Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial Lancet Infect Dis 14 31-9 2013


Whole-genome sequencing shows that patient-to-patient transmission rarely accounts for acquisition of Staphylococcus aureus on an intensive care unit

13.01.2014 (Botond Lakatos)
Price JR et al.: Whole-genome sequencing shows that patient-to-patient transmission rarely accounts for acquisition of Staphylococcus aureus on an intensive care unit CID December 12. Epub ahead of print 2013

Inactivation of Hepatitis C Virus Infectivity by Human Breast Milk

06.01.14 (Barbara Jakopp)
Stephanie Pfaender: Inactivation of Hepatitis C Virus Infectivity by Human Breast Milk JID 208 1943-52 2013